Anaplastic Pleomorphic Xanthoastrocytoma

Anaplastic Pleomorphic Xanthoastrocytoma — Trials · CancerIndex

Clinical trials

Registered studies

6 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 3
Recruiting: 1
Ph III recruiting: 0
Growth YoY: —
Industry share: 67%
Top sponsor: Jazz Pharmaceuticals
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1)

clinicaltrialsPublishedShowing 1–1 of 1 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03973918	Study of Binimetinib With Encorafenib in Adults With Recurrent BRAF V600-Mutated HGG(BRAF)	terminated	Phase 2	5	Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER	1	Oct 31, 2024	clinicaltrials

Data updated 22 days agoSource updated Oct 31, 2024source: clinicaltrials